Versant Venture Capital V, L.P.

CIK 1589097 · last filed 2022-06-07

Versant Venture Capital V, L.P. is a corporate insider who has filed 3 SEC Form 4 insider transactions across 3 companies since 2018. The most recent filing, for RPTX, was dated Jun 7, 2022. Across all open-market trades the lifetime net is −$88.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $7.8M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$7.79M

Companies

3

Total Filings

3

Lifetime Open-Market Net

-$88.07M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
Repare Therapeutics Inc. (RPTX) Delisted	10%+ Owner	2,344,451	$2.65	$6.21M	-$91.89M	1	2022-06-07
APRE	10%+ Owner	2,852,656	$0.69	$1.96M	$40.00M	1	2019-10-07
CRSP	10%+ Owner	117,173	$49.80	$5.84M	-$36.18M	1	2018-04-24

Recent Filings

3 filings

Form 4 transactions across all companies, newest first.

Filed	Symbol	Action	Net Shares	Net $	Link
2022-06-07	Repare Therapeutics Inc. (RPTX) Delisted	Mixed	−14,500,000	-$91.89M	EDGAR
2019-10-07	APRE	Mixed	+22,719,888	$40.00M	EDGAR
2018-04-24	CRSP	Mixed	−4,213,958	-$36.18M	EDGAR

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.